Skip to main content
Premium Trial:

Request an Annual Quote

GeneGo Licenses GVK's Compound DB for Use with Pathway Software

NEW YORK (GenomeWeb News) - GVK Biosciences of Hyderabad, India, has licensed its Medicinal Chemistry Database to the software and data-services company GeneGo, the companies said today.
GeneGo plans to integrate the MedChem database into its Metacore and MetaDrug platforms.
GeneGo's vice president of business development, Julie Bryant, said the agreement marks the first time the company has licensed third-party content for use in its platforms.
Pharmaceutical researchers use GeneGo's MetaCore 4.3 to target, identify, and validate biomarkers for diseases and toxicity. They use its MetaDrug 4.2 to help predict human metabolism, toxicity, and the effects of small molecule compounds.
GVK's Medicinal Chemistry Database contains more than 650,000 compounds accompanied by biological and pharmacological information, according to the company.
Financial terms of the agreement were not released.

Filed under

The Scan

Back as Director

A court has reinstated Nicole Boivin as director of the Max Planck Institute for the Science of Human History, Science reports.

Research, But Implementation?

Francis Collins reflects on his years as the director of the US National Institutes of Health with NPR.

For the False Negatives

The Guardian writes that the UK Health Security Agency is considering legal action against the lab that reported thousands of false negative COVID-19 test results.

Genome Biology Papers Present Epigenetics Benchmarking Resource, Genomic Architecture Maps of Peanuts, More

In Genome Biology this week: DNA methylation data for seven reference cell lines, three-dimensional genome architecture maps of peanut lines, and more.